AN HLA-ASSOCIATED NONRESPONSIVENESS TO MELITTIN - A COMPONENT OF BEE VENOM

被引:38
|
作者
LYMPANY, P
KEMENY, DM
WELSH, KI
LEE, TH
机构
[1] UNITED MED & DENT SCH GUYS & ST THOMAS HOSP,GUYS HOSP,DEPT ALLERGY & ALLIED RESP DISORDERS,LONDON SE1 9RT,ENGLAND
[2] UNITED MED & DENT SCH GUYS & ST THOMAS HOSP,GUYS HOSP,DEPT TISSUE TYPING,LONDON SE1 9RT,ENGLAND
关键词
D O I
10.1016/S0091-6749(05)80061-2
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Previous work has demonstrated a close association between certain histocompatibility antigens and the gene that controls the IgE response to certain ragweed allergens. For example, there is a 90% association between IgE production to the short ragweed allergen, Amb a V, and an HLA class II allele. To assess whether these HLA linkages are specific for ragweed, we have investigated the association between HLA antigens and the capacity of individuals to mount a specific IgE response to melittin in patients with bee-venom allergy. Twenty-two subjects with bee-venom sensitivity, 22 healthy beekeepers without bee-venom allergy, and a normal population of 149 unselected individuals were studied. With serologic tissue typing and restriction fragment length polymorphism analysis, we have demonstrated a significant decrease in the HLA-DR4 and DQw3 alleles in subjects who are allergic to melittin compared to the control populations. There was also a negative association between the presence of HLA-DR4 and DQw3 alleles with the capacity of the individuals to mount an IgE response to phospholipase A2 (PLA2). The bee-venom sensitive subjects had a slightly lower titer of anti-PLA2 IgG when these subjects were compared to the bee-venom insensitive beekeepers. These results support the view that either HLA-DR or HLA-DQ has a protective role in controlling the IgE immune response. Lack of an IgE response to melittin or PLA2 is unlikely to be due to a failure to recognize allergen. © 1990 Mosby-Year Book, Inc.
引用
收藏
页码:160 / 170
页数:11
相关论文
共 50 条
  • [41] An LCMS method for the assay of melittin in cosmetic formulations containing bee venom
    Jonans Tusiimire
    Jennifer Wallace
    Mark Dufton
    John Parkinson
    Carol J. Clements
    Louise Young
    Jin Kyu Park
    Jong Woon Jeon
    David G. Watson
    Analytical and Bioanalytical Chemistry, 2015, 407 : 3627 - 3635
  • [42] The discovery and use of HLA-associated epitopes as drugs
    Urban, RG
    Chicz, RM
    Hedley, ML
    CRITICAL REVIEWS IN IMMUNOLOGY, 1997, 17 (5-6) : 387 - 397
  • [43] ROLE AND EXPRESSION OF THE HLA-ASSOCIATED INVARIANT CHAIN
    STRUBIN, M
    TONNELLE, C
    LONG, EO
    MACH, B
    EXPERIENTIA, 1986, 42 (06): : 672 - 672
  • [44] In Silico Prediction of HLA-Associated Drug Hypersensitivity
    Yao, Xin-Qiu
    Jariwala, Shashank
    Grant, Barry J.
    BIOPHYSICAL JOURNAL, 2017, 112 (03) : 293A - 294A
  • [45] IS ALL GENETIC (HEREDITARY) HEMOCHROMATOSIS HLA-ASSOCIATED
    POWELL, LW
    BASSETT, ML
    AXELSEN, E
    FERLUGA, J
    HALLIDAY, JW
    ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1988, 526 : 23 - 33
  • [46] Melittin: A Key Composition of Honey Bee Venom with Diverse Pharmaceutical Function
    Huang, Sheng
    Wang, Jianhua
    Wang, Xiaozhong
    Li, Chenghong
    PROCEEDINGS OF THE 2016 INTERNATIONAL CONFERENCE ON BIOLOGICAL ENGINEERING AND PHARMACY (BEP 2016), 2016, 3 : 193 - 197
  • [47] Selective Ruthenium Labeling of the Tryptophan Residue in the Bee Venom Peptide Melittin
    Perekalin, Dmitry S.
    Novikov, Valentin V.
    Pavlov, Alexander A.
    Ivanov, Igor A.
    Anisimova, Natalia Yu
    Kopylov, Alexey N.
    Volkov, Dmitry S.
    Seregina, Irina F.
    Bolshov, Michail A.
    Kudinov, Alexander R.
    CHEMISTRY-A EUROPEAN JOURNAL, 2015, 21 (13) : 4923 - 4925
  • [48] Application of bee venom and its main constituent melittin for cancer treatment
    Cui-cui Liu
    Ding-jun Hao
    Qian Zhang
    Jing An
    Jing-jing Zhao
    Bo Chen
    Ling-ling Zhang
    Hao Yang
    Cancer Chemotherapy and Pharmacology, 2016, 78 : 1113 - 1130
  • [49] Application of bee venom and its main constituent melittin for cancer treatment
    Liu, Cui-cui
    Hao, Ding-jun
    Zhang, Qian
    An, Jing
    Zhao, Jing-jing
    Chen, Bo
    Zhang, Ling-ling
    Yang, Hao
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2016, 78 (06) : 1113 - 1130
  • [50] KARYOMEGALIC INTERSTITIAL NEPHRITIS - AN HLA-ASSOCIATED DISEASE
    SPOENDLIN, M
    BRUNNER, F
    THIEL, G
    MIHATSCH, M
    KIDNEY INTERNATIONAL, 1993, 44 (01) : 259 - 259